Your browser doesn't support javascript.
loading
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia.
Bajaj, Jeevisha; Hamilton, Michael; Shima, Yutaka; Chambers, Kendall; Spinler, Kyle; Van Nostrand, Eric L; Yee, Brian A; Blue, Steven M; Chen, Michael; Rizzeri, David; Chuah, Charles; Oehler, Vivian G; Broome, H Elizabeth; Sasik, Roman; Scott-Browne, James; Rao, Anjana; Yeo, Gene W; Reya, Tannishtha.
Afiliación
  • Bajaj J; Department of Pharmacology, University of California San Diego, School of Medicine, La Jolla, CA, USA. Jeevisha_Bajaj@URMC.Rochester.edu.
  • Hamilton M; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA. Jeevisha_Bajaj@URMC.Rochester.edu.
  • Shima Y; Moores Cancer Center, University of California San Diego, School of Medicine, La Jolla, CA, USA. Jeevisha_Bajaj@URMC.Rochester.edu.
  • Chambers K; Department of Medicine, University of California San Diego, School of Medicine, La Jolla, CA, USA. Jeevisha_Bajaj@URMC.Rochester.edu.
  • Spinler K; Department of Biomedical Genetics and Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA. Jeevisha_Bajaj@URMC.Rochester.edu.
  • Van Nostrand EL; Department of Pharmacology, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Yee BA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
  • Blue SM; Moores Cancer Center, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Chen M; Department of Medicine, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Rizzeri D; Department of Pharmacology, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Chuah C; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
  • Oehler VG; Moores Cancer Center, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Broome HE; Department of Medicine, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Sasik R; Department of Pharmacology, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Scott-Browne J; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
  • Rao A; Moores Cancer Center, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Yeo GW; Department of Medicine, University of California San Diego, School of Medicine, La Jolla, CA, USA.
  • Reya T; Department of Pharmacology, University of California San Diego, School of Medicine, La Jolla, CA, USA.
Nat Cancer ; 1(4): 410-422, 2020 04.
Article en En | MEDLINE | ID: mdl-34109316
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide Aguda / Crisis Blástica / Proteínas de Unión al ARN / Proteínas del Tejido Nervioso Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Nat Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Leucemia Mieloide Aguda / Crisis Blástica / Proteínas de Unión al ARN / Proteínas del Tejido Nervioso Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Nat Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos